Unknown

Dataset Information

0

Transcriptional control of the gonococcal ompA gene by the MisR/MisS two-component regulatory system.


ABSTRACT: Neisseria gonorrhoeae, the causative agent of gonorrhea, is an exclusive human pathogen whose growing antibiotic resistance is causing worldwide concern. The increasing rise of antibiotic resistance expressed by gonococci highlights the need to find alternative approaches to current gonorrhea treatment such as vaccine development or novel therapeutics. The gonococcal OmpA protein was previously identified as a potential vaccine candidate due to its conservation and stable expression amongst strains of Neisseria gonorrhoeae. However, factors that might modulate levels of OmpA and therefore potential vaccine efficacy are unknown. Earlier work indicated that ompA is part of the MisR/MisS regulon and suggested that it was a MisR-activated gene. Herein, we confirmed MisR/MisS regulation of ompA and report that the MisR response regulator can bind upstream of the ompA translational start codon. Further, we describe the contribution of a DNA sequence upstream of the ompA promoter that is critical for MisR activation of ompA transcription. Our results provide a framework for understanding the transcription of gonococcal ompA through a regulatory system known to be important for survival of gonococci during experimental infection.

SUBMITTER: Holley CL 

PROVIDER: S-EPMC7286886 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Transcriptional control of the gonococcal ompA gene by the MisR/MisS two-component regulatory system.

Holley Concerta L CL   Ayala Julio C JC   Shafer William M WM  

Scientific reports 20200610 1


Neisseria gonorrhoeae, the causative agent of gonorrhea, is an exclusive human pathogen whose growing antibiotic resistance is causing worldwide concern. The increasing rise of antibiotic resistance expressed by gonococci highlights the need to find alternative approaches to current gonorrhea treatment such as vaccine development or novel therapeutics. The gonococcal OmpA protein was previously identified as a potential vaccine candidate due to its conservation and stable expression amongst stra  ...[more]

Similar Datasets

| S-EPMC2223465 | biostudies-literature
| S-EPMC1539957 | biostudies-literature
| S-EPMC2889410 | biostudies-other
| S-EPMC2825934 | biostudies-literature
| S-EPMC2258621 | biostudies-literature
2013-09-17 | E-GEOD-50825 | biostudies-arrayexpress
2013-09-17 | GSE50825 | GEO
| S-EPMC6528607 | biostudies-literature
| S-EPMC3116866 | biostudies-literature
2024-04-02 | GSE225902 | GEO